BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 4397178)

  • 1. Evidence that the hypotensive action of methyldopa is mediated by central actions of methylnoradrenaline.
    Henning M; Rubenson A
    J Pharm Pharmacol; 1971 Jun; 23(6):407-11. PubMed ID: 4397178
    [No Abstract]   [Full Text] [Related]  

  • 2. Analysis of the action of m-tyrosine on blood pressure in the conscious rat: evidence for a central hypotensive effect.
    Rubenson A
    J Pharm Pharmacol; 1971 Jun; 23(6):412-9. PubMed ID: 4397179
    [No Abstract]   [Full Text] [Related]  

  • 3. Further studies on the mechanism of the central hypotensive effect of L-dopa, DL-m-tyrosine and L-alpha-methyldopa.
    Rubenson A
    J Pharm Pharmacol; 1971 Mar; 23(3):228-30. PubMed ID: 4396899
    [No Abstract]   [Full Text] [Related]  

  • 4. 4,4,6-trimethyl-3,4-dihydropyrimidine-2-thiol, an effective inhibitor of dopamine-beta-hydroxylation in vivo.
    Porter CC; Torchiana ML
    Biochem Pharmacol; 1971 Jan; 20(1):183-91. PubMed ID: 4398314
    [No Abstract]   [Full Text] [Related]  

  • 5. Antagonistic actions of alpha-methylnoradrenaline derived from alpha-methyldopa.
    Boakes RJ; Candy JM; Wolstencroft JH
    J Pharm Pharmacol; 1973 Jun; 25(6):491-2. PubMed ID: 4146591
    [No Abstract]   [Full Text] [Related]  

  • 6. Blood pressure and noradrenaline levels after treatment with alpha-methyldopa, alpha-methyldopamine and alpha-methyl-m-tyrosine.
    Henning M
    J Pharm Pharmacol; 1967 Nov; 19(11):775-9. PubMed ID: 4383705
    [No Abstract]   [Full Text] [Related]  

  • 7. On the localization of the hypotensive effect of L-dopa.
    Henning M; Rubenson A; Trolin G
    J Pharm Pharmacol; 1972 Jun; 24(6):447-51. PubMed ID: 4403826
    [No Abstract]   [Full Text] [Related]  

  • 8. Further evidence for a central hypotensive action of -methyldopa.
    Finch L; Haeusler G
    Br J Pharmacol; 1972 May; 45(1):167P-168P. PubMed ID: 5041484
    [No Abstract]   [Full Text] [Related]  

  • 9. The significance of the relative potencies of norepinephrine and alpha-methylnoradrenaline for the mode of action of alpha-methyldopa.
    Trinker FR
    J Pharm Pharmacol; 1971 Apr; 23(4):306-8. PubMed ID: 4396912
    [No Abstract]   [Full Text] [Related]  

  • 10. An investigation of alpha-methyl amino-acids and their derivatives on isolated tissue preparations.
    Gulati OD; Parikh HM; Ringe SY; Sherlekar ML
    Br J Pharmacol; 1970 Dec; 40(4):689-701. PubMed ID: 5495174
    [TBL] [Abstract][Full Text] [Related]  

  • 11. -Sympathetic receptor stimulation in the brain and hypotensive activity of -methyldopa.
    Heise A; Kroneberg G
    Eur J Pharmacol; 1972 Feb; 17(2):315-7. PubMed ID: 4402101
    [No Abstract]   [Full Text] [Related]  

  • 12. On the role of alpha-methyldopamine in the antihypertensive effect of alpha-methyldopa.
    Waldmeier P; Hedwal PR; Maître L
    Naunyn Schmiedebergs Arch Pharmacol; 1975; 289(3):303-14. PubMed ID: 169487
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Further evidence for a central hypotensive action of alpha-methyldopa in both the rat and cat.
    Finch L; Haeusler G
    Br J Pharmacol; 1973 Feb; 47(2):217-28. PubMed ID: 4722038
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Central hypotensive effect of alpha-methyldopa.
    Henning M; van Zwieten PA
    J Pharm Pharmacol; 1968 Jun; 20(6):409-17. PubMed ID: 4386523
    [No Abstract]   [Full Text] [Related]  

  • 15. Liberation of alpha-methyldopamine as a "false" sympathetic transmitter after pretreatment of cats with alpha-methyldopa and disulfiram.
    Thoenen H; Haefely W; Gey KF; Hürlmann A
    Naunyn Schmiedebergs Arch Exp Pathol Pharmakol; 1967; 258(2):181-96. PubMed ID: 4385111
    [No Abstract]   [Full Text] [Related]  

  • 16. Studies on the mode of action of alpha-methyldopa.
    Henning M
    Acta Physiol Scand Suppl; 1969; 322():1-37. PubMed ID: 4311985
    [No Abstract]   [Full Text] [Related]  

  • 17. Studies on the formation of alpha-methylnoradrenaline in hypertensive patients treated with alpha-methyldopa.
    Muscholl E; Rahn KH
    Naunyn Schmiedebergs Arch Exp Pathol Pharmakol; 1968; 259(2):215-6. PubMed ID: 4232699
    [No Abstract]   [Full Text] [Related]  

  • 18. L-DOPA induced effects on motor activity in mice after inhibition of dopamine-beta-hydroxylase.
    Strömberg U; Svensson TH
    Psychopharmacologia; 1971; 19(1):53-60. PubMed ID: 5089105
    [No Abstract]   [Full Text] [Related]  

  • 19. Importance of central serotonin neurons in the hypotensive action of methyldopa in the rat.
    Choy VJ; Chalmers J
    Clin Exp Pharmacol Physiol; 1984; 11(1):37-44. PubMed ID: 6713735
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Cardiovascular activity of alpha methyldopa metabolites in the dog].
    Wepierre J; Doreau C; Papin A; Paultre C; Cohen Y
    Arch Int Pharmacodyn Ther; 1973 Nov; 206(1):135-49. PubMed ID: 4149582
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.